TP53 and metabolic syndrome: We captured tumour suppressor gene TP53, which helps to maintain the integrity of a genome (23), as a key target in ER-negative breast cancer (Figures 2D and 4A) and a high impact gene in dyslipidemia homozygote (Figure 3B).